Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.
Biological and targeted therapies
This article outlines the importance of homologous recombination repair pathway in development of breast carcinoma (BC), and the influence of gene alterations in chemotherapy treated BC samples.
Editor, Jade Parker recently spoke with world-renowned sarcoma expert, Robin L Jones. In this interview discover challenges in the diagnosis, treatment and clinical trials of sarcoma and other rare tumors.
As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.
A review of the latest epidemiological evidence strengthens a causal link between the consumption of alcohol and cancers at seven sites in the body.
Editor Jade Parker, speaks to Peter Campbell (Wellcome Trust Sanger Institute, Cambridge, UK) to find out how he is working towards identifying the preventable causes of cancer.
Dr Hafez Halawani talks to Oncology Central regarding the predictive and prognostic potential of tumor location in metastatic colorectal cancer – a debate that was perpetuated with the presentation of the Venook et al study at the 2016 ASCO meeting.
Pathology and cancer biology
In this editorial from Future Oncology the different types of endometrial cancer are appraised.
Prevention and screening
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.
This article reviews yttrium-90 radioembolization of hepatocellular carcinoma from a clinical perspective, considering safety and efficacy, patient selection, and optimal assessment and management of patients.
Millions of people are living with the long-term consequences of cancer and its treatment, but currently there is very little research on the problems they face and how these can be tackled.
As part of our spotlight we spoke with Daniel B Brown from the Vanderbilt Cancer Center (TN, USA) about his work in the field of interventional oncology and minimally invasive surgery.